Showing results (101-110 of 747) with videos related to
Sort By:
Pageof 75
Clinical Lipidology|April 17, 2012
Gene therapy for dyslipidemia: a review of gene replacement and gene inhibition strategiesSadik H Kassim, James M Wilson, Daniel J RaderCurrent Opinion in Lipidology|February 12, 2011
Functional validation of new pathways in lipoprotein metabolism identified by human geneticsRobert C Bauer, Ioannis M Stylianou, Daniel J RaderJournal of Clinical Lipidology|February 18, 2014
JCL roundtable: drug treatment of severe forms of familial hypercholesterolemiaW Virgil Brown, Daniel J Rader, Anne C GoldbergCurrent Cardiology Reports|September 20, 2012
Targeting high density lipoproteins in the prevention of cardiovascular disease?Daniel B Larach, Emil M deGoma, Daniel J RaderTrends in Molecular Medicine|September 6, 2015
Mining the social mediomeDavid A Asch, Daniel J Rader, Raina M MerchantCurrent Opinion in Lipidology|February 19, 2015
HDL re-examinedG Kees Hovingh, Daniel J Rader, Robert A HegeleCardiovascular Diabetology|May 4, 2007
Gene transfer of wild-type apoA-I and apoA-I Milano reduce atherosclerosis to a similar extentCorinna Lebherz, Julio Sanmiguel, James M Wilson, et al.Prostaglandins & Other Lipid Mediators|November 24, 2005
12/15-Lipoxygenase gene disruption and vitamin E administration diminish atherosclerosis and oxidative stress in apolipoprotein E deficient mice through a final common pathwayLei Zhao, Domenico Praticò, Daniel J Rader, et al.Atherosclerosis|September 5, 2002
Combined effects of cholesterol reduction and apolipoprotein A-I expression on atherosclerosis in LDL receptor deficient miceMasa-aki Kawashiri, YuZhen Zhang, Ellen Puré, et al.Current Atherosclerosis Reports|December 10, 2003
Noninvasive atherosclerosis imaging for predicting cardiovascular events and assessing therapeutic interventionsDouglas S Jacoby, Emile R Mohler III, Daniel J RaderPageof 75